OncoPharm cover image

Neoadjuvant Chemo In Breast Cancer

OncoPharm

00:00

The Role of ERPR in Cancer Survival

There was no difference in outcomes where women got chemo first or they got chemo after surgery. 10 BID for five years not 20 a day but 10 BID that's what the Tomoxfen dosing was back at that time. In 1988 this is even pre-zofran 10% of people in each arm had six to ten episodes of vomiting in a 24 hour period which certainly doesn't happen in the zofran era now.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app